[1]
|
T. Bjornheden, A. Babiy, G. Bondjers, G., and O. Wiklund, Accumulation of lipoprotein fractions and subfractions in the arterial wall, determined in an in vitro perfusion system, Atherosclerosis, 123 (1996), 43-560.
|
[2]
|
C. A. Cobbold, J. A. Sherratt, and S. J. R. Maxwell, Lipoprotein oxidation and its significance for atherosclerosis: a mathematical approach, Bull. Math. Biol., 64 (2002), 65-95.
|
[3]
|
M. A. Creager, M. A. and Braunwald, E. eds., "Atlas of Vascular Disease," $2^{nd}$ edition, Current Medicine, Inc. (2003)
|
[4]
|
A. Daugherty, and D. L. Rateri, Pathogenesis of atherosclerotic lesions, Cardiol. Rev., 1 (1993), 157-166.
|
[5]
|
J. Fan, and T. Watanabe, Inflammatory reactions in the pathogenesis of atherosclerosis, JAT, 10(2) (2003), 63-71.
|
[6]
|
R. Franssen, A. W. M. Schimmel, S. I. van Leuven, S. C. S. Wolfkamp, E. S.G. Stroes, and G. M. Dallinga-Thie, In vivo inflammation does not impair ABCA1-mediated cholesterol efflux capacity of HDL, Cholesterol, 2012 (2012), 1-8.
|
[7]
|
J. L. Goldstein, Y. K. Ho, S. K. Basu, and M. S. Brown, Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoproteins, producing massive cholesterol deposition, Proc. Natl. Acad. Sci. USA, 76 (1977), 333-337
|
[8]
|
J. Hubbard and B. West, "Differential Equations: A Dynamical Systems Approach," Springer-Verlag, New York, (1991)
|
[9]
|
A. I. Ibragimov, C. J. McNeal, L. R. Ritter, and J. R. Walton, A mathematical model of atherogenesis as an inflammatory response, Math. Med. and Biol., 22 (2005), 305-333
|
[10]
|
A. I. Ibragimov, C. J. McNeal, L. R. Ritter, and J. R. Walton, Stability analysis of a model of atherogenesis: An energy estimate approach, J. of Comp. and Math. Meth. in Med., 9(2) (2008), 121-142
|
[11]
|
A. I. Ibragimov, L. R. Ritter, and J. R Walton, Stability analysis of a reaction-diffusion system modeling atherogenesis, SIAM J. Appl. Math., 70(7) (2010), 2150-2185
|
[12]
|
K. U. Ingold, V. W. Bowry, R. Stocker, and C. Walling, Autoxidation and antioxidation by $\alpha$-tocopherol and ubiquinol in homogeneous solution and in aqueous dispersions of lipids: unrecognized consequences of lipid particle size as exemplified by oxidation of human low density lipoprotein, Proc. Natl. Acad. Sci. USA, 90 (1993), 45-49.
|
[13]
|
I. Jailal, G. L. Vega, S. M. and Grundy, Physologic levels of ascorbate inhibit the oxidative modification of low density lipoprotein, Atherosclerosis, 82 (1990), 185-191.
|
[14]
|
W. Khovidhunkit, M. S. Kim, R. A. Memon, J. K. Shigenaga, A. H. Moser, K. R. Feingold, and C. Grunfeld, Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host, Journal of Lipid Research, 45(7) (2004), 1169-1196
|
[15]
|
P. Libby, P. M. Ridker, and A. Maseri, Inflammation and atherosclerosis, Circulation, 105(9) (2002), 11351143.
|
[16]
|
L. B. Neilsen, Transfer of low density lipoprotein into the arterial wall and risk of atherosclerosis, Atherosclerosis, 123 (1996), 1-15.
|
[17]
|
J. Neuzil, S. R. Thomas, and R. Stocker, Requirement for, promotion, or inhibition by $\alpha$-tocopherol of radical-induced initiation of plasma lipoprotein lipid peroxidation, Free Radic. Biol. Med., 22 (1997), 57-71
|
[18]
|
J. E. Packer, T. F. Slater, and R. L. Willson, Direct observation of a free radical interaction between vitamin E and vitamin C, Nature, 278 (1979), 737-738
|
[19]
|
E. A. Podrez, E. Poliakov, Z. Shen, R. Zhang, Y. Deng, M. Sun, P. J. Finton, L. Shan, B. Gugiu, P. L. Fox, H. F. Hoff, R. G. Salomon, and S. L. Hazen, Identification of a novel family of oxidized phospholipids that serve as ligands for the macrophage scavenger receptor CD36, J. Biol. Chem., 277 (2002), 38503-38516
|
[20]
|
Russell Ross, Cell biology of atherosclerosis, Annu. Rev. Physiol., 57 (1995), 791-804.
|
[21]
|
Russell Ross, Atherosclerosis-An inflammatory disease, N. Engl. J. Med., 340(2) (1999), 115-126
|
[22]
|
D. c. Schwenke, and T. E. Carew, Initiation of atherosclerotic lesions in cholesterol fed rabbits. II Selective retention of LDL vs. Selective increases in LDL permeability in susceptible sites of arteries, Arteriosclerosis, 9 (1989), 908-918
|
[23]
|
H. C. Stary, B. Chandler, S. Glagov, J. R. Guyton, W. Insull Jr., M. E. Rosenfeld, S. A. Schaffer, C. J. Schwartz, W. D. Wagner, and R. W. Wissler, A definition of initial, fatty streak, and intermediate lesions of atherosclerosis: a report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Special report., Arterioscler. Thromb., 14 (1994), 840-856
|
[24]
|
D. Steinberg, Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime, Nat. Med., 8 (2002), 1211-1217
|
[25]
|
A. R. Tall, Plasma high density lipoproteins: metabolism and relationship to atherogenesis, J. Clin. Invest., 86 (1990), 379-384
|
[26]
|
N. Wang, D. Lan, W. Chen, F. Matsuura, and A. Tall, ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins, Proc. Natl. Acad. Sci. USA, 101(26) (2004), 9774-9779
|